138 related articles for article (PubMed ID: 20464627)
1. Gender difference in bone metastasis of human small cell lung cancer, SBC-5 cells in natural killer-cell depleted severe combined immunodeficient mice.
Sakaguchi S; Goto H; Hanibuchi M; Otsuka S; Ogino H; Kakiuchi S; Uehara H; Yano S; Nishioka Y; Sone S
Clin Exp Metastasis; 2010 May; 27(5):351-9. PubMed ID: 20464627
[TBL] [Abstract][Full Text] [Related]
2. Bone metastasis model with multiorgan dissemination of human small-cell lung cancer (SBC-5) cells in natural killer cell-depleted SCID mice.
Miki T; Yano S; Hanibuchi M; Sone S
Oncol Res; 2000; 12(5):209-17. PubMed ID: 11417746
[TBL] [Abstract][Full Text] [Related]
3. Parathyroid hormone-related protein (PTHrP) is responsible for production of bone metastasis, but not visceral metastasis, by human small cell lung cancer SBC-5 cells in natural killer cell-depleted SCID mice.
Miki T; Yano S; Hanibuchi M; Kanematsu T; Muguruma H; Sone S
Int J Cancer; 2004 Feb; 108(4):511-5. PubMed ID: 14696114
[TBL] [Abstract][Full Text] [Related]
4. Combined therapy with a new bisphosphonate, minodronate (YM529), and chemotherapy for multiple organ metastases of small cell lung cancer cells in severe combined immunodeficient mice.
Yano S; Zhang H; Hanibuchi M; Miki T; Goto H; Uehara H; Sone S
Clin Cancer Res; 2003 Nov; 9(14):5380-5. PubMed ID: 14614023
[TBL] [Abstract][Full Text] [Related]
5. A novel bisphosphonate minodronate (YM529) specifically inhibits osteolytic bone metastasis produced by human small-cell lung cancer cells in NK-cell depleted SCID mice.
Zhang H; Yano S; Miki T; Goto H; Kanematsu T; Muguruma H; Uehara H; Sone S
Clin Exp Metastasis; 2003; 20(2):153-9. PubMed ID: 12705636
[TBL] [Abstract][Full Text] [Related]
6. Intensification therapy with anti-parathyroid hormone-related protein antibody plus zoledronic acid for bone metastases of small cell lung cancer cells in severe combined immunodeficient mice.
Yamada T; Muguruma H; Yano S; Ikuta K; Ogino H; Kakiuchi S; Hanibuchi M; Uehara H; Nishioka Y; Sone S
Mol Cancer Ther; 2009 Jan; 8(1):119-26. PubMed ID: 19139120
[TBL] [Abstract][Full Text] [Related]
7. Antitumor vascular strategy for controlling experimental metastatic spread of human small-cell lung cancer cells with ZD6474 in natural killer cell-depleted severe combined immunodeficient mice.
Yano S; Muguruma H; Matsumori Y; Goto H; Nakataki E; Edakuni N; Tomimoto H; Kakiuchi S; Yamamoto A; Uehara H; Ryan A; Sone S
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8789-98. PubMed ID: 16361567
[TBL] [Abstract][Full Text] [Related]
8. Reveromycin A inhibits osteolytic bone metastasis of small-cell lung cancer cells, SBC-5, through an antiosteoclastic activity.
Muguruma H; Yano S; Kakiuchi S; Uehara H; Kawatani M; Osada H; Sone S
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8822-8. PubMed ID: 16361571
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of multiorgan metastases of human lung cancer cells genetically engineered to produce cytokines and reversal using chimeric monoclonal antibodies in natural killer cell-depleted severe combined immunodeficient mice.
Sone S; Yano S; Hanibuchi M; Nokihara H; Nishimura N; Miki T; Nishioka Y; Shinohara T
Cancer Chemother Pharmacol; 1999; 43 Suppl():S26-31. PubMed ID: 10357555
[TBL] [Abstract][Full Text] [Related]
10. A bone metastasis model with osteolytic and osteoblastic properties of human lung cancer ACC-LC-319/bone2 in natural killer cell-depleted severe combined immunodeficient mice.
Otsuka S; Hanibuchi M; Ikuta K; Yano S; Goto H; Ogino H; Yamada T; Kakiuchi S; Nishioka Y; Takahashi T; Sone S
Oncol Res; 2009; 17(11-12):581-91. PubMed ID: 19806789
[TBL] [Abstract][Full Text] [Related]
11. Follistatin suppresses the production of experimental multiple-organ metastasis by small cell lung cancer cells in natural killer cell-depleted SCID mice.
Ogino H; Yano S; Kakiuchi S; Muguruma H; Ikuta K; Hanibuchi M; Uehara H; Tsuchida K; Sugino H; Sone S
Clin Cancer Res; 2008 Feb; 14(3):660-7. PubMed ID: 18245525
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic efficacy of mouse-human chimeric anti-ganglioside GM2 monoclonal antibody against multiple organ micrometastases of human lung cancer in NK cell-depleted SCID mice.
Hanibuchi M; Yano S; Nishioka Y; Yanagawa H; Kawano T; Sone S
Int J Cancer; 1998 Nov; 78(4):480-5. PubMed ID: 9797137
[TBL] [Abstract][Full Text] [Related]
13. Parathyroid hormone-related protein varies with sex and androgen status in nonsmall cell lung cancer.
Montgrain PR; Quintana R; Rascon Y; Burton DW; Deftos LJ; Casillas A; Hastings RH
Cancer; 2007 Sep; 110(6):1313-20. PubMed ID: 17676588
[TBL] [Abstract][Full Text] [Related]
14. Immunological circumvention of multiple organ metastases of multidrug resistant human small cell lung cancer cells by mouse-human chimeric anti-ganglioside GM2 antibody KM966.
Hanibuchi M; Yano S; Nishioka Y; Yanagawa H; Miki T; Sone S
Clin Exp Metastasis; 2000; 18(5):353-60. PubMed ID: 11467766
[TBL] [Abstract][Full Text] [Related]
15. Parathyroid hormone-related protein and ezrin are up-regulated in human lung cancer bone metastases.
Deng X; Tannehill-Gregg SH; Nadella MV; He G; Levine A; Cao Y; Rosol TJ
Clin Exp Metastasis; 2007; 24(2):107-19. PubMed ID: 17370040
[TBL] [Abstract][Full Text] [Related]
16. Macrophage stimulating protein promotes liver metastases of small cell lung cancer cells by affecting the organ microenvironment.
Sato S; Hanibuchi M; Kuramoto T; Yamamori N; Goto H; Ogawa H; Mitsuhashi A; Van TT; Kakiuchi S; Akiyama S; Nishioka Y; Sone S
Clin Exp Metastasis; 2013 Mar; 30(3):333-44. PubMed ID: 23011677
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide analysis of organ-preferential metastasis of human small cell lung cancer in mice.
Kakiuchi S; Daigo Y; Tsunoda T; Yano S; Sone S; Nakamura Y
Mol Cancer Res; 2003 May; 1(7):485-99. PubMed ID: 12754296
[TBL] [Abstract][Full Text] [Related]
18. A new quinoline derivative MS-209 reverses multidrug resistance and inhibits multiorgan metastases by P-glycoprotein-expressing human small cell lung cancer cells.
Nokihara H; Yano S; Nishioka Y; Hanibuchi M; Higasida T; Tsuruo T; Sone S
Jpn J Cancer Res; 2001 Jul; 92(7):785-92. PubMed ID: 11473730
[TBL] [Abstract][Full Text] [Related]
19. The effect of down regulation of calcineurin Aα by lentiviral vector-mediated RNAi on the biological behavior of small-cell lung cancer and its bone metastasis.
Ma NQ; Liu LL; Min J; Wang JW; Jiang WF; Liu Y; Feng YG; Su HC; Feng YM; Zhang HL
Clin Exp Metastasis; 2011 Dec; 28(8):765-78. PubMed ID: 21785830
[TBL] [Abstract][Full Text] [Related]
20. RANKL-induced CCL22/macrophage-derived chemokine produced from osteoclasts potentially promotes the bone metastasis of lung cancer expressing its receptor CCR4.
Nakamura ES; Koizumi K; Kobayashi M; Saitoh Y; Arita Y; Nakayama T; Sakurai H; Yoshie O; Saiki I
Clin Exp Metastasis; 2006; 23(1):9-18. PubMed ID: 16821125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
